Search

everythinglearnresearchcommunity

for

Search:↓

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Tph cells are linked to the severity of systemic lupus erythematosus.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Hair loss in lupus patients indicates higher disease activity.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Certain skin symptoms can help detect and manage systemic lupus.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Fever and rash can be early signs of lupus.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Hair chemicals don't cause SLE but may increase skin issues in those with SLE.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.